藥 物 回 收
|
| |
| The United Kingdom: Class 3 Medicines Recall: Accord Healthcare Ltd, Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (English only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution (batch number: UK25B06) after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. The incorrectly labelled ampoules are the same product and contain the same active ingredient but have Korean language labels and different batch details.
The product is indicated for the treatment of reversible bronchospasm associated with chronic obstructive pulmonary disease. It is also indicated, when used concomitantly with inhaled beta2-agonists, for treatment of reversible airways obstruction as in acute and chronic asthma.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-ipratropium-bromide-500-microgram-slash-2ml-nebuliser-solution-el-25-a-slash-45
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Friday, Oct 24, 2025
Issued at HKT 17:15
|
| |
